BMS’s Cancer Trial Showcases Potential for Checkpoint Inhibitors
Bristol Myers Squibb’s recent phase III success provided the first late-stage confirmation for a novel…
April 29, 2021 - 5 minutes
Innate Pharma
How Immuno-Oncology Contributes to the Fight Against Covid-19
As the Covid-19 pandemic sweeps the world, cancer research is proving a valuable resource for…
July 6, 2020 - 7 minutes
Sofinnova Partners Raises €333M for its Newest Life Sciences-Focused Fund
Sofinnova Partners, Europe’s largest VC focused on life sciences, has raised €333M to fund early-stage…
October 17, 2019 - 2 minutes
Innate Pharma Raises €62M IPO to Develop Antibody Drugs for Cancer
The French company Innate Pharma has raised a Nasdaq IPO of €62.1M ($68.8M) to fund…
October 17, 2019 - 2 minutes
Innate’s Cancer Immunotherapy Combo Beats Standard Treatment Twofold
A combination cancer immunotherapy from French biotech Innate Pharma was twice as effective at treating…
October 22, 2018 - 2 minutes
Two Biotechs Team Up to Test their Cancer Antibody Combo in the Clinic
Innate Pharma and MedImmune will test the combination of Innate’s cancer antibody and the checkpoint…
January 30, 2018 - 3 minutes
Grab the Tissues: Here are the 8 Biggest European Biotech Clinical Failures of 2017
As 2016 was a tough year for biotech, 2017 was under pressure to turn things…
December 12, 2017 - 7 minutes
French Biotech Strikes Deal with Novo Nordisk for New Cancer Drug
Novo Nordisk has handed over its anti-cancer antibody to Innate Pharma in a new deal…
June 6, 2017 - 2 minutes
How is Biotech Transforming Pharma’s R&D Model?
Since the early 2000s, pharma has undergone a major reorganization. What roles do strategic alliances…
April 6, 2017 - 4 minutes
Infographic: What’s in Europe’s Immuno-oncology Pipeline?
While some might accuse the field of being over-hyped, immuno-oncology continues to attract attention and investment for…
February 13, 2017 - 2 minutes
French Biotech’s Checkpoint Inhibitor Fails Phase II Leukemia Trial
Innate Pharma's checkpoint inhibitor candidate lirilumab missed its primary endpoint in a Phase II trial,…
February 6, 2017 - 2 minutes
How is European Immuno-Oncology fighting Blood Cancer?
From leukemia to multiple myeloma, biotech is working hard to cure blood cancer. This year's…
December 6, 2016 - 4 minutes
